Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Article in The Journal of Headache and Pain (March 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
Article in Frontiers in Neurology (March 2024)
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
Article in Neurology and Therapy (January 2024)